1
Bongers, Mathilda L., Hogervorst, Janneke G. F., Schouten, Leo J., Goldbohm, R. Alexandra, Schouten, Harry C., van den Brandt, Piet A.
Veröffentlicht in: Bongers , M L , Hogervorst , J G F , Schouten , L J , Goldbohm , R A , Schouten , H C & van den Brandt , P A 2012 , ' Dietary Acrylamide Intake and the Risk of Lymphatic Malignancies: The Netherlands Cohort Study on Diet and Cancer ' , PLOS ONE , vol. 7 , no. 6 , e38016 . https://doi.org/10.1371/journal.pone.0038016;
2012
Veröffentlicht in: Bongers , M L , Hogervorst , J G F , Schouten , L J , Goldbohm , R A , Schouten , H C & van den Brandt , P A 2012 , ' Dietary Acrylamide Intake and the Risk of Lymphatic Malignancies: The Netherlands Cohort Study on Diet and Cancer ' , PLOS ONE , vol. 7 , no. 6 , e38016 . https://doi.org/10.1371/journal.pone.0038016;
2012
2
Dinmohamed, Avinash G., Issa, Djamila E., van der Poel, Marjolein W. M., Schouten, Harry C., Lugtenburg, Pieternella J., Chamuleau, Martine E. D., Zweegman, Sonja, Visser, Otto
Veröffentlicht in: Dinmohamed , A G , Issa , D E , van der Poel , M W M , Schouten , H C , Lugtenburg , P J , Chamuleau , M E D , Zweegman , S & Visser , O 2017 , ' Treatment and relative survival in very elderly patients with DLBCL in The Netherlands : a population-based study, 1989 to 2015 ' , Blood , vol. 1 , no. 21 , pp. 1839-1841 . https://doi.org/10.1182/bloodadvances.2017011031 , https://doi.org/10.1182/bloodadvances.2017011031;
2017
Veröffentlicht in: Dinmohamed , A G , Issa , D E , van der Poel , M W M , Schouten , H C , Lugtenburg , P J , Chamuleau , M E D , Zweegman , S & Visser , O 2017 , ' Treatment and relative survival in very elderly patients with DLBCL in The Netherlands : a population-based study, 1989 to 2015 ' , Blood , vol. 1 , no. 21 , pp. 1839-1841 . https://doi.org/10.1182/bloodadvances.2017011031 , https://doi.org/10.1182/bloodadvances.2017011031;
2017
3
Slot, Stefanie, Raymakers, Reinier A. P., Schaap, Nicolaas, Span, Lambert F. R., Koene, Harry R., Kersting, Sabina, Boekhorst, Peter A. W. te, Westerman, Matthijs, Schouten, Harry C., Zweegman, Sonja
Veröffentlicht in: Slot , S , Raymakers , R A P , Schaap , N , Span , L F R , Koene , H R , Kersting , S , Boekhorst , P A W T , Westerman , M , Schouten , H C & Zweegman , S 2019 , ' Ruxolitinib in Myelofibrosis and Baseline Thrombocytopenia in Real Life : Results in Dutch Patients and Review of the Literature ' , Clinical lymphoma myeloma & leukemia , vol. 19 , no. 10 , pp. 624-634 . https://doi.org/10.1016/j.clml.2019.07.005;
2019
Veröffentlicht in: Slot , S , Raymakers , R A P , Schaap , N , Span , L F R , Koene , H R , Kersting , S , Boekhorst , P A W T , Westerman , M , Schouten , H C & Zweegman , S 2019 , ' Ruxolitinib in Myelofibrosis and Baseline Thrombocytopenia in Real Life : Results in Dutch Patients and Review of the Literature ' , Clinical lymphoma myeloma & leukemia , vol. 19 , no. 10 , pp. 624-634 . https://doi.org/10.1016/j.clml.2019.07.005;
2019
4
Ossenkoppele, Gert J, Stussi, Georg, Maertens, Johan, van Montfort, Kees, Biemond, Bart J, Breems, Dimitri, Ferrant, August, Graux, Carlos, de Greef, Georgine E, Halkes, C J M, Hoogendoorn, Mels, Hollestein, Rene M, Jongen-Lavrencic, Mojca, Levin, Mark D, van de Loosdrecht, Arjan A, van Marwijk Kooij, Marinus, van Norden, Yvette, Pabst, Thomas, Schouten, Harry C, Vellenga, Edo, Verhoef, Gregor E G, de Weerdt, Okke, Wijermans, Pierre, Passweg, Jakob R, Löwenberg, Bob
2012
2012
5
Ossenkoppele, Gert Jan, Stussi, Georg, Maertens, Johan, van Montfort, Kees, Biemond, Bart J., Breems, Dimitri, Ferrant, August, Graux, Carlos, de Greef, Georgine E., Halkes, C. J. M., Hoogendoorn, Mels, Hollestein, Rene M., Jongen-Lavrencic, Mojca, Levin, Mark-David, van de Loosdrecht, Arjan A., Kooij, Marinus van Marwijk, van Norden, Yvette, Pabst, Thomas, Schouten, Harry C., Vellenga, Edo, Verhoef, Gregor E. G., de Weerdt, Okke, Wijermans, Pierre, Passweg, Jakob R., Lowenberg, Bob
Veröffentlicht in: Ossenkoppele , G J , Stussi , G , Maertens , J , van Montfort , K , Biemond , B J , Breems , D , Ferrant , A , Graux , C , de Greef , G E , Halkes , C J M , Hoogendoorn , M , Hollestein , R M , Jongen-Lavrencic , M , Levin , M-D , van de Loosdrecht , A A , Kooij , M V M , van Norden , Y , Pabst , T , Schouten , H C , Vellenga , E , Verhoef , G E G , de Weerdt , O , Wijermans , P , Passweg , J R & Lowenberg , B 2012 , ' Addition of bevacizumab to chemotherapy in acute myeloid leukemia at older age: a randomized phase 2 trial of the Dutch-Belgian Cooperative Trial Group for Hemato-Oncology (HOVON) and the Swiss Group for Clinical Cancer Research (SAKK) ' , Blood , vol. 120 , no. 24 , pp. 4706-4711 . https://doi.org/10.1182/blood-2012-04-420596;
2012
Veröffentlicht in: Ossenkoppele , G J , Stussi , G , Maertens , J , van Montfort , K , Biemond , B J , Breems , D , Ferrant , A , Graux , C , de Greef , G E , Halkes , C J M , Hoogendoorn , M , Hollestein , R M , Jongen-Lavrencic , M , Levin , M-D , van de Loosdrecht , A A , Kooij , M V M , van Norden , Y , Pabst , T , Schouten , H C , Vellenga , E , Verhoef , G E G , de Weerdt , O , Wijermans , P , Passweg , J R & Lowenberg , B 2012 , ' Addition of bevacizumab to chemotherapy in acute myeloid leukemia at older age: a randomized phase 2 trial of the Dutch-Belgian Cooperative Trial Group for Hemato-Oncology (HOVON) and the Swiss Group for Clinical Cancer Research (SAKK) ' , Blood , vol. 120 , no. 24 , pp. 4706-4711 . https://doi.org/10.1182/blood-2012-04-420596;
2012